{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:06:31Z","timestamp":1788876391113,"version":"build-2803163510"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T00:00:00Z","timestamp":1773360000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020432","name":"Austrian Center for Medical Innovation and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020432","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Particle Therapy"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijpt.2026.101312","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T00:23:45Z","timestamp":1774311825000},"page":"101312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Advancing Particle Therapy to Improve Cancer Care: Report on \u201c2nd World Forum on Particle Therapy\u201d"],"prefix":"10.1016","volume":"20","author":[{"given":"Eugen","family":"Hug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9692-706X","authenticated-orcid":false,"given":"Neil G.","family":"Burnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"2nd","given":"Charles B.","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe A.","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk J.","family":"De Ruysscher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay","family":"Flanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Fossati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandan","family":"Guha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad S.","family":"Hoppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiao-Ming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ijpt.2026.101312_bib1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.ijpt.2026.101312_bib2","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/0959-8049(92)90256-2","article-title":"The role of local treatment in the cure of cancer","volume":"28A","author":"Tubiana","year":"1992","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijpt.2026.101312_bib3","unstructured":"International Atomic Energy Agency (IAEA). Radiotherapy In Cancer Care: Facing the Global Challenge. 2017.\u00a0Accessed 27 August 2025.\u00a0https:\/\/www-pub.iaea.org\/MTCD\/Publications\/PDF\/P1638_web.pdf."},{"key":"10.1016\/j.ijpt.2026.101312_bib4","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20230334","article-title":"The use of radiotherapy, surgery and chemotherapy in the curative treatment of cancer: results from the FORTY (Favourable Outcomes from RadioTherapY) project","author":"Mee","year":"2023","journal-title":"Brit J Radiol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101312_bib5","doi-asserted-by":"crossref","first-page":"e245","DOI":"10.1016\/S1470-2045(23)00184-5","article-title":"Global democratisation of proton radiotherapy","volume":"24","author":"Yan","year":"2023","journal-title":"Lancet Oncol"},{"issue":"1114","key":"10.1016\/j.ijpt.2026.101312_bib6","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200183","article-title":"Particle therapy in the future of precision therapy","volume":"93","author":"Schaub","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijpt.2026.101312_bib7","unstructured":"Particle Therapy Co-Operative Group (PTCOG) website 2025.\u00a0Accessed August 27, 2025.\u00a0https:\/\/www.ptcog.site\/index.php\/patient-statistics-2."},{"key":"10.1016\/j.ijpt.2026.101312_bib8","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nrclinonc.2009.183","article-title":"Charged particles in radiation oncology","volume":"7","author":"Durante","year":"2010","journal-title":"Nat Rev Clin Oncol"},{"issue":"8","key":"10.1016\/j.ijpt.2026.101312_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1038\/nrclinonc.2017.30","article-title":"Charged-particle therapy in cancer: clinical uses and future perspectives","volume":"14","author":"Durante","year":"2017","journal-title":"Nat Rev Clin Oncol"},{"issue":"1115","key":"10.1016\/j.ijpt.2026.101312_bib10","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200172","article-title":"The 20th Gray lecture 2019: health and heavy ions","volume":"93","author":"Blakely","year":"2020","journal-title":"Br J Radiol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101312_bib11","doi-asserted-by":"crossref","first-page":"621","DOI":"10.4143\/crt.2021.299","article-title":"Who will benefit from charged-particle therapy?","volume":"53","author":"Kim","year":"2021","journal-title":"Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101312_bib12","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/1097-0142(19800815)46:4<633::AID-CNCR2820460402>3.0.CO;2-O","article-title":"Current status of clinical particle radiotherapy at Lawrence Berkeley Laboratory","volume":"46","author":"Castro","year":"1980","journal-title":"Cancer"},{"key":"10.1016\/j.ijpt.2026.101312_bib13","series-title":"Proton Therapy Physics","year":"2019"},{"key":"10.1016\/j.ijpt.2026.101312_bib14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1148\/47.5.487","article-title":"Radiological use of fast protons","volume":"47","author":"Wilson","year":"1946","journal-title":"Radiology"},{"key":"10.1016\/j.ijpt.2026.101312_bib15","series-title":"Radiobiology for the Ra\u00a0Diologist","author":"Hall","year":"1978"},{"issue":"7","key":"10.1016\/j.ijpt.2026.101312_bib16","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/1878-0261.12677","article-title":"Particle therapy in Europe","volume":"14","author":"Grau","year":"2020","journal-title":"Mol Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib17","first-page":"30","article-title":"Radiotherapy with heavy charged particles at Lawrence Berkeley Laboratory","volume":"31","author":"Castro","year":"1980","journal-title":"J Can Assoc Radiol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101312_bib18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0360-3016(94)90550-9","article-title":"Experience in charged particle irradiation of tumors of the skull base: 1977-1992","volume":"29","author":"Castro","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.ijpt.2026.101312_bib19","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.3109\/0284186X.2010.498432","article-title":"Heidelberg Ion Therapy Center (HIT): initial clinical experience in the first 80 patients","volume":"49","author":"Combs","year":"2010","journal-title":"Acta Oncol"},{"issue":"11","key":"10.1016\/j.ijpt.2026.101312_bib20","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/jme.2009.030981","article-title":"Fallacies in the arguments for new technology: the case of proton therapy","volume":"35","author":"Hofmann","year":"2009","journal-title":"J Med Ethics"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101312_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.clon.2022.11.017","article-title":"Developing a national infrastructure for proton beam therapy trials","volume":"35","author":"Rieu","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101312_bib22","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.semradonc.2023.06.006","article-title":"Advances and challenges in conducting clinical trials with proton beam therapy","volume":"33","author":"Choi","year":"2023","journal-title":"Semin Radiat Oncol"},{"issue":"16","key":"10.1016\/j.ijpt.2026.101312_bib23","article-title":"Phase III randomized trial of intensity-modulated proton therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for the treatment of head and neck oropharyngeal carcinoma (OPC)","volume":"42","author":"Frank","year":"2024","journal-title":"J Clin Oncol"},{"issue":"10524","key":"10.1016\/j.ijpt.2026.101312_bib24","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0140-6736(25)01962-2","article-title":"Proton versus photon radiotherapy for patients with oropharyngeal cancer in the USA: a multicentre, randomised, open-label, non-inferiority phase 3 trial","volume":"407","author":"Frank","year":"2026","journal-title":"Lancet"},{"issue":"33","key":"10.1016\/j.ijpt.2026.101312_bib25","doi-asserted-by":"crossref","first-page":"3858","DOI":"10.1200\/JCO.22.01148","article-title":"Randomized phase II trial of proton craniospinal irradiation versus photon involved-field radiotherapy for patients with solid tumor leptomeningeal metastasis","volume":"40","author":"Yang","year":"2022","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.ijpt.2026.101312_bib26","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1200\/JCO.19.02503","article-title":"Randomized phase IIB trial of proton beam therapy versus intensity-modulated radiation therapy for locally advanced esophageal cancer","volume":"38","author":"Lin","year":"2020","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101312_bib27","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.ijrobp.2018.02.022","article-title":"Phase 2 study of stereotactic body radiation therapy and stereotactic body proton therapy for high-risk, medically inoperable, early-stage non-small cell lung cancer","volume":"101","author":"Nantavithya","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"22","key":"10.1016\/j.ijpt.2026.101312_bib28","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1002\/cncr.34965","article-title":"Proton beam radiotherapy versus transarterial chemoembolization for hepatocellular carcinoma: results of a randomized clinical trial","volume":"129","author":"Bush","year":"2023","journal-title":"Cancer"},{"issue":"18","key":"10.1016\/j.ijpt.2026.101312_bib29","first-page":"1813","article-title":"Bayesian adaptive randomization trial of passive scattering proton therapy and intensity-modulated photon radiotherapy for locally advanced non-small-cell lung","volume":"36","author":"Liao","year":"2018","journal-title":"Cancer\u00a0J Clin Oncol"},{"issue":"8","key":"10.1016\/j.ijpt.2026.101312_bib30","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1093\/neuonc\/noab040","article-title":"A prospective phase II randomized trial of proton radiotherapy vs intensity-modulated radiotherapy for patients with newly diagnosed glioblastoma","volume":"23","author":"Brown","year":"2021","journal-title":"Neuro Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib31","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ijrobp.2024.08.012","article-title":"Prostate advanced radiation technologies investigating quality of life (PARTIQoL): phase III randomized clinical trial of proton therapy vs. IMRT for localized prostate cancer","volume":"120","author":"Efstathiou","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101312_bib32","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13014-016-0640-8","article-title":"Establishing the feasibility of the dosimetric compliance criteria of RTOG 1308: phase III randomized trial comparing overall survival after photon versus proton radiochemotherapy for inoperable stage II-IIIB NSCLC","volume":"11","author":"Giaddui","year":"2016","journal-title":"Radiat Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib33","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.clon.2023.11.027","article-title":"Hitting the target: developing high-quality evidence for proton beam therapy through randomised controlled trials","volume":"36","author":"Hudson","year":"2024","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.ijpt.2026.101312_bib34","unstructured":"Danish Centre for Particle Therapy 2025.\u00a0Accessed August\u00a027,\u00a02025.\u00a0https:\/\/www.en.auh.dk\/departments\/the-danish-centre-for-particle-therapy\/research\/clinical-trials\/."},{"key":"10.1016\/j.ijpt.2026.101312_bib35","unstructured":"National Institute of Health National Library of Medicine 2025.\u00a0Accessed August\u00a027,\u00a02025.\u00a0https:\/\/clinicaltrials.gov\/search."},{"key":"10.1016\/j.ijpt.2026.101312_bib36","first-page":"147","article-title":"TORPEdO: a phase III trial of intensity-modulated proton beam therapy versus intensity-modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer","volume":"38","author":"Thomson","year":"2022","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101312_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(26)00314-4","article-title":"Proton beam therapy for oropharyngeal cancer (TORPEdO): a phase 3, randomised controlled trial","author":"Thomson","year":"2026","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101312_bib38","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0360-3016(96)00352-5","article-title":"A randomized trial on dose response in radiation therapy of low-grade cerebral glioma. European Organization for Research and Treatment of Cancer (EORTC) study 22844","volume":"36","author":"Karim","year":"1996","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101312_bib39","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1200\/JCO.2002.09.126","article-title":"Prospective randomized trial of low-versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group\/Radiation Therapy Oncology Group\/Eastern Cooperative Oncology Group study","volume":"20","author":"Shaw","year":"2002","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib40","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ijrobp.2006.12.059","article-title":"Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas","volume":"68","author":"Schulz-Ertner","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib41","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00066-022-02002-4","article-title":"Proton and carbon ion beam treatment with active raster scanning method in 147 patients with skull base chordoma at the Heidelberg Ion Beam Therapy Center-a single-center experience","volume":"199","author":"Mattke","year":"2023","journal-title":"Strahlenther Onkol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib42","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1470-2045(16)30648-9","article-title":"A genome-based model for adjusting radiotherapy dose (GARD): a retrospective, cohort-based study","volume":"18","author":"Scott","year":"2017","journal-title":"Lancet Oncol"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101312_bib43","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jtho.2020.11.008","article-title":"Personalizing radiotherapy prescription dose using genomic markers of radiosensitivity and normal tissue toxicity in NSCLC","volume":"16","author":"Scott","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101312_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101165","article-title":"Genomic identification of sarcoma radiosensitivity and the clinical implications for radiation dose personalization","volume":"14","author":"Yang","year":"2021","journal-title":"Transl Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib45","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/s12885-024-12151-7","article-title":"Habitat escalated adaptive therapy (HEAT): a phase 2 trial utilizing radiomic habitat-directed and genomic-adjusted radiation dose (GARD) optimization for high-grade soft tissue sarcoma","volume":"24","author":"Naghavi","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijpt.2026.101312_bib46","unstructured":"SACRO trial. Sacral Chordoma: Surgery Versus Definitive Radiation Therapy in Primary Localized Disease (SACRO).\u00a0Accessed\u00a0August\u00a027,\u00a02025.\u00a0https:\/\/clinicaltrials.gov\/study\/NCT02986516."},{"issue":"6","key":"10.1016\/j.ijpt.2026.101312_bib47","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.3390\/cancers15061660","article-title":"Pragmatic, prospective comparative effectiveness trial of carbon ion therapy, surgery, and proton therapy for the management of pelvic sarcomas (soft tissue\/bone) involving the bone: the PROSPER study rationale and design","volume":"15","author":"Hoppe","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib48","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.ijrobp.2024.07.2152","article-title":"NRG oncology white paper on the relative biological effectiveness in proton therapy","volume":"121","author":"Paganetti","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101312_bib49","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.radonc.2022.08.008","article-title":"Organs at risk dose constraints in carbon ion radiotherapy at MedAustron: translations between LEM and MKM RBE models and preliminary clinical results","volume":"175","author":"Grosshagauer","year":"2022","journal-title":"Radiother Oncol"},{"issue":"7","key":"10.1016\/j.ijpt.2026.101312_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/acm2.14321","article-title":"The sensitivity of radiobiological models in carbon ion radiotherapy (CIRT) and its consequences on the clinical treatment plan: Differences between LEM and MKM models","volume":"25","author":"G\u00f3ra","year":"2024","journal-title":"J Appl Clin Med Phys"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101312_bib51","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.ijrobp.2024.02.025","article-title":"Understanding relative biological effectiveness and clinical outcome of prostate cancer therapy using particle irradiation: analysis of tumor control probability with the modified microdosimetric kinetic model","volume":"119","author":"Besuglow","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"12","key":"10.1016\/j.ijpt.2026.101312_bib52","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1007\/s00066-023-02158-7","article-title":"High-LET charged particles: radiobiology and application for new approaches in radiotherapy","volume":"199","author":"Helm","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.ijpt.2026.101312_bib53","first-page":"1","article-title":"Are charged particles a good match for combination with immunotherapy? Current knowledge and perspectives","volume":"376","author":"Helm","year":"2023","journal-title":"Int Rev Cell Mol Biol"},{"key":"10.1016\/j.ijpt.2026.101312_bib54","article-title":"Immune modulatory roles of radioimmunotherapy: biological principles and clinical prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ijpt.2026.101312_bib55","article-title":"Particle beam radiobiology status and challenges: a PTCOG radiobiology subcommittee report","volume":"13","author":"Ahmad","year":"2024","journal-title":"Int J Part Ther"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101312_bib56","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/09553002.2024.2324472","article-title":"Kaplan lecture 2023: lymphopenia in particle therapy","volume":"100","author":"Durante","year":"2024","journal-title":"Int J Radiat Biol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib57","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ijrobp.2020.01.032","article-title":"Absolute lymphocyte count predicts abscopal responses and outcomes in patients receiving combined immunotherapy and radiation therapy: analysis of 3 phase 1\/2 trials","volume":"108","author":"Chen","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101312_bib58","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1093\/jrr\/rrx005","article-title":"Intravenous dendritic cell administration enhances suppression of lung metastasis induced by carbon-ion irradiation","volume":"58","author":"Ando","year":"2017","journal-title":"J Radiat Res"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101312_bib59","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.3390\/cancers12103022","article-title":"Carbon Ion Radiobiology","volume":"12","author":"Tinganelli","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib60","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2020.09.041","article-title":"Reduction of lung metastases in a mouse osteosarcoma model treated with carbon ions and immune checkpoint inhibitors","volume":"109","author":"Helm","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101312_bib61","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.radonc.2022.05.003","article-title":"FLASH with carbon ions: tumor control, normal tissue sparing, and distal metastasis in a mouse osteosarcoma model","volume":"175","author":"Tinganelli","year":"2022","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib62","doi-asserted-by":"crossref","first-page":"7305","DOI":"10.1038\/s41598-025-91872-6","article-title":"Carbon minibeam radiation therapy results in tumor growth delay in an osteosarcoma murine model","volume":"15","author":"Bertho","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101312_bib63","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1158\/1535-7163.MCT-18-0558","article-title":"TGF\u03b2 blockade enhances radiotherapy abscopal efficacy effects in combination with anti-PD1 and anti-CD137 immunostimulatory monoclonal antibodies","volume":"18","author":"Rodr\u00cdguez-Ruiz","year":"2019","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.ijpt.2026.101312_bib64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41392-022-01102-y","article-title":"Radiotherapy combined with immunotherapy: the dawn of cancer treatment","volume":"7","author":"Zhang","year":"2022","journal-title":"Sig Transduct Target Ther"},{"key":"10.1016\/j.ijpt.2026.101312_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1201500","article-title":"A review on lymphocyte radiosensitivity and its impact on radiotherapy","volume":"13","author":"Paganetti","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.ijpt.2026.101312_bib66","unstructured":"Calvo FA, Meiri\u00f1o R, Garcia-Cardosa M, Vidorreta M, Burguete J. The forgotten effect of radiation therapy in vessels and circulating blood. Tadiation Therapy. The Forgotten Effect of Radiation Therapy on Vessels and Circulating Blood. MReadings: MR in RT, 9th Edition, ASTRO 2023. 2023 siemens-healthineers.com\/magnetom-world-rt pp.\u00a024-30.\u00a0Accessed\u00a0August\u00a027,\u00a02025.\u00a0https:\/\/cdn0.scrvt.com\/7b8dc61d55f0deedb776692474194f7c\/7ef7b780a90e2c99\/358402e6c8a2\/siemens-healthineers_magnetom-world_MReadings_MR-in-RT_9th_Edition_ASTRO_2023.pdf."},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib67","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib68","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1172\/JCI131234","article-title":"Methylation of immune synapse genes modulates tumor immunogenicity","volume":"130","author":"Berglund","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ijpt.2026.101312_bib69","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/215847a0","article-title":"Effect of high dose rates on survival of mammalian cells","volume":"215","author":"Town","year":"1967","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib70","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ijrobp.2025.03.047","article-title":"Requirements and study design for the next proton FLASH clinical trials: an international multidisciplinary delphi consensus","volume":"123","author":"Klaver","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101312_bib71","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.ijrobp.2025.05.076","article-title":"Advancing proton FLASH radiation therapy: innovations, techniques, and clinical potentials","volume":"123","author":"Ma","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101312_bib72","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1016\/j.ijrobp.2024.11.089","article-title":"FLASH bragg-peak irradiation with a therapeutic carbon ion beam: first in vivo results","volume":"121","author":"Tinganelli","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101312_bib73","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.radonc.2021.09.011","article-title":"FLASH radiotherapy: considerations for multibeam and hypofractionation dose delivery","volume":"164","author":"Mackay","year":"2021","journal-title":"Radiother Oncol"},{"issue":"1107","key":"10.1016\/j.ijpt.2026.101312_bib74","article-title":"Physical advantages of particles: protons and light ions","volume":"93","author":"J\u00e4kel","year":"2020","journal-title":"Rev\u00a0Br J Radiol"},{"key":"10.1016\/j.ijpt.2026.101312_bib75","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.semcancer.2023.11.008","article-title":"Hypoxia as a potential inducer of immune tolerance, tumor plasticity and a driver of tumor mutational burden: impact on cancer immunotherapy","volume":"97","author":"Abou Khouzam","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.ijpt.2026.101312_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110434","article-title":"Particle arc therapy: status and potential","volume":"199","author":"Mein","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2026.101312_bib77","first-page":"873","article-title":"Exploring energy selection methods for robust biologically optimized carbon ion arc for head&neck cancer patients","volume":"14","author":"Volz","year":"2024","journal-title":"Health\u00a0Technol"},{"issue":"15","key":"10.1016\/j.ijpt.2026.101312_bib78","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6560\/ac65d3","article-title":"Roadmap: helium ion therapy","volume":"67","author":"Mairani","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijpt.2026.101312_bib79","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1088\/1361-6560\/ac9d1f","article-title":"Universal and dynamic ridge filter for pencil beam scanning particle therapy: a novel concept for ultra-fast treatment delivery","volume":"67","author":"Maradia","year":"2022","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ijpt.2026.101312_bib80","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190873","article-title":"Proton beam therapy - perspectives on the National Health Service England clinical service and research programme","author":"Burnet","year":"2020","journal-title":"Br J Radiol"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101312_bib81","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1002\/ijc.32908","article-title":"Cardiac mortality after radiotherapy, chemotherapy and endocrine therapy for breast cancer: cohort study of 2 million women from 57 cancer registries in 22 countries","volume":"147","author":"Henson","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijpt.2026.101312_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2024.103732","article-title":"Best Practice for Patient-centred Radiotherapy in Clinical Trials and Beyond-A National Multidisciplinary Consensus","volume":"39","author":"Green","year":"2025","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101312_bib83","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/j.ijrobp.2019.03.016","article-title":"Downstream effect of a proton treatment center on an Academic Medical Center","volume":"104","author":"Remick","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib84","doi-asserted-by":"crossref","first-page":"e42","DOI":"10.1016\/S1470-2045(19)30794-6","article-title":"How public health services pay for radiotherapy in Europe: an ESTRO-HERO analysis of reimbursement","volume":"21","author":"Lievens","year":"2020","journal-title":"Lancet Oncol"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101312_bib85","article-title":"Assessment of proton beam therapy use among patients with newly diagnosed cancer in the US, 2004-2018","volume":"5","author":"Nogueira","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.ijpt.2026.101312_bib86","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/j.ijrobp.2023.12.041","article-title":"Temporal evolution and diagnostic diversification of patients receiving proton therapy in the United States: a ten-year trend analysis (2012 to 2021) from the National Association for Proton Therapy","volume":"119","author":"Hartsell","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101312_bib87","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20211175","article-title":"Estimating the percentage of patients who might benefit from Proton Beam Therapy instead of X-ray radiotherapy","author":"Burnet","year":"2022","journal-title":"Br J Radiol"},{"key":"10.1016\/j.ijpt.2026.101312_bib88","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.radonc.2018.10.022","article-title":"Patterns of proton therapy use in pediatric cancer management in 2016: an international survey","volume":"132","author":"Journy","year":"2019","journal-title":"Radiother Oncol"},{"issue":"6","key":"10.1016\/j.ijpt.2026.101312_bib89","article-title":"The pediatric proton and photon therapy comparison cohort: study design for a multicenter retrospective cohort to investigate subsequent cancers after pediatric radiation therapy","volume":"8","author":"Berrington de Gonz\u00e1lez","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.ijpt.2026.101312_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109816","article-title":"An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia","volume":"187","author":"Ahern","year":"2023","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib91","doi-asserted-by":"crossref","first-page":"31","DOI":"10.14338\/IJPT-19-00079.1","article-title":"Estimating the number of patients eligible for carbon ion radiotherapy in the United States","volume":"7","author":"Malouff","year":"2020","journal-title":"Int J Part Ther"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jtho.2020.10.013","article-title":"Toxicity and survival after intensity-modulated proton therapy versus passive scattering proton therapy for NSCLC","volume":"16","author":"Gjyshi","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101312_bib93","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.clon.2023.02.018","article-title":"Radiosensitivity Index is not fit to be used for dose adjustments: a pan-cancer analysis","volume":"35","author":"Mistry","year":"2023","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"8","key":"10.1016\/j.ijpt.2026.101312_bib94","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1136\/medethics-2012-101290","article-title":"Position statement on ethics, equipoise and research on charged particle radiation therapy","volume":"40","author":"Sheehan","year":"2014","journal-title":"J Med Ethics"},{"key":"10.1016\/j.ijpt.2026.101312_bib95","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejca.2020.02.050","article-title":"The European Organisation for research and treatment of cancer, state of science in radiation oncology and priorities for clinical trials meeting report","volume":"131","author":"Thomas","year":"2020","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijpt.2026.101312_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110019","article-title":"Proton and photon radiotherapy in stage III NSCLC: effects on hematological toxicity and adjuvant immune therapy","volume":"190","author":"Cortiula","year":"2024","journal-title":"Radiother Oncol"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib97","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0167-8140(89)90131-X","article-title":"Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up","volume":"15","author":"Turesson","year":"1989","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2026.101312_bib98","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.radonc.2022.01.018","article-title":"The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain tumours treated with photon or proton irradiation","volume":"168","author":"De Roeck","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2026.101312_bib99","unstructured":"EORTC-ESTRO Radiation Infrastructure for Europe - E2RADIatE.\u00a0Accessed August 27,\u00a02025.\u00a0https:\/\/project.eortc.org\/e2-radiate."},{"issue":"6","key":"10.1016\/j.ijpt.2026.101312_bib100","doi-asserted-by":"crossref","first-page":"pkad088","DOI":"10.1093\/jncics\/pkad088","article-title":"Large-Scale Meta-GWAS reveals common genetic factors linked to radiation-induced acute toxicities across cancers","volume":"7","author":"Naderi","year":"2023","journal-title":"JNCI Cancer Spectrum"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101312_bib101","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.ijrobp.2024.01.007","article-title":"Prospective analysis of radiation-induced contrast enhancement and health-related quality of life after proton therapy for central nervous system and skull base tumors","volume":"118","author":"L\u00fctgendorf-Caucig","year":"2024","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib102","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ijrobp.2018.01.013","article-title":"National Cancer Institute Workshop on proton therapy for children: considerations regarding brainstem injury","volume":"101","author":"Haas-Kogan","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijpt.2026.101312_bib103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.radonc.2021.08.016","article-title":"Does the uncertainty in relative biological effectiveness affect patient treatment in proton therapy?","volume":"163","author":"S\u00f8rensen","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijpt.2026.101312_bib104","article-title":"Proton-based re-irradiation of locally recurrent, pediatric brain tumors with immediate proximity to the Brainstem","author":"Hug","year":"2025","journal-title":"Int J Particle Ther"},{"issue":"2","key":"10.1016\/j.ijpt.2026.101312_bib105","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/bjc.2011.235","article-title":"Designing phase II trials in cancer: a systematic review and guidance","volume":"105","author":"Brown","year":"2011","journal-title":"Br J Cancer"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib106","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s13014-020-01538-y","article-title":"PITChing (professional organisations, innovative trial designs and collaborative approach) for evidence generation for proton therapy","volume":"15","author":"Chilukuri","year":"2020","journal-title":"Radiat Oncol"},{"issue":"8","key":"10.1016\/j.ijpt.2026.101312_bib107","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/jnci\/djae084","article-title":"The use of master protocols for efficient trial design to evaluate radiotherapy interventions: a systematic review","volume":"116","author":"Gilbert","year":"2024","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"10.1016\/j.ijpt.2026.101312_bib108","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.jtbi.2009.10.021","article-title":"A mathematical model of brain tumour response to radiotherapy and chemotherapy considering radiobiological aspects","volume":"262","author":"Barazzuol","year":"2010","journal-title":"J Theor Biol"},{"issue":"10","key":"10.1016\/j.ijpt.2026.101312_bib109","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.clon.2012.06.003","article-title":"Methodological considerations in the evaluation of radiotherapy technologies","volume":"24","author":"Burnet","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"1","key":"10.1016\/j.ijpt.2026.101312_bib110","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11060-021-03847-y","article-title":"Comparison of hypothyroidism, growth hormone deficiency, and adrenal insufficiency following proton and photon radiotherapy in children with medulloblastoma","volume":"155","author":"Aldrich","year":"2021","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.ijpt.2026.101312_bib111","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1470-2045(23)00146-8","article-title":"Proton therapy and limited surgery for paediatric and adolescent patients with craniopharyngioma (RT2CR): a single-arm, phase 2 study","volume":"24","author":"Merchant","year":"2023","journal-title":"Lancet Oncol"},{"issue":"7","key":"10.1016\/j.ijpt.2026.101312_bib112","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1002\/cncr.28536","article-title":"Comparative effectiveness study of patient-reported outcomes after proton therapy or intensity-modulated radiotherapy for prostate cancer","volume":"120","author":"Hoppe","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/j.ijpt.2026.101312_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijrobp.2025.06.3876","article-title":"Comparison of contemporary radiotherapy approaches in combined modality treatment on pediatric high-risk classic hodgkin lymphoma study: AHOD 1331","author":"Hoppe","year":"2025","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"18","key":"10.1016\/j.ijpt.2026.101312_bib114","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.ijpt.2026.101312_bib115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.clon.2019.05.009","article-title":"Radiotherapy quality assurance for the CHHiP Trial: conventional versus hypofractionated high-dose intensity-modulated radiotherapy in prostate cancer","volume":"31","author":"Naismith","year":"2019","journal-title":"Clin Oncol (R Coll Radiol)"}],"container-title":["International Journal of Particle Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518026000156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2331518026000156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T21:53:03Z","timestamp":1780955583000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2331518026000156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":115,"alternative-id":["S2331518026000156"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101312","relation":{},"ISSN":["2331-5180"],"issn-type":[{"value":"2331-5180","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Advancing Particle Therapy to Improve Cancer Care: Report on \u201c2nd World Forum on Particle Therapy\u201d","name":"articletitle","label":"Article Title"},{"value":"International Journal of Particle Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpt.2026.101312","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of Particle Therapy Co-operative Group.","name":"copyright","label":"Copyright"}],"article-number":"101312"}}